Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
SKF to publish Q3 report on 30 October
To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers: Link to web event: https://www.investis-live.com/skf/6703fe36b2cedb000e390899/aherus Sweden: +46 8 5051 0031 UK / International: +44 207 107 0613 To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers:Link to web event:https://www.investis-live.com/skf/6703fe36b2cedb000e390899/aherus Sweden : +46 8 5051 0031UK /...
PR Newswire
16/10/2024
Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical…
Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical OfficerNewly established role at Essential Pharma further strengthens leadership team and supports global growth Dr Liz Holmes' rare disease and oncology expertise to be instrumental in bringing clinical stage immunotherapy asset Hu14.18 to marketEgham, UK – 16 October 2024– Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume,...
Nasdaq GlobeNewswire
16/10/2024
Tecan provides update on current trading and revised outlook for full year 2024
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan provides update on current trading and revised outlook for full year 2024 Substantial reductions in OEM customer forecasts as the main factor negatively impacting outlook for 2024 since last update in AugustLife Sciences Business continues to face a challenging market environment but is showing sequential growth in the second half of 2024Rigorous cost-down program being executed...
Nasdaq GlobeNewswire
16/10/2024
Olivier Falut appointed EUROAPI's Chief Financial Officer
Press Release Paris – October 16, 2024 –Olivier Falut has been appointed EUROAPI's Chief Financial Officer, effective October 17, 2024, and will be a member of the Executive Committee. He is taking over from Evelyne Nguyen, who will remain within the company until the end of October to ensure a smooth transition. “I am delighted to welcome Olivier, a seasoned Chief Financial Officer with extensive experience in the industrial sector. He will play a decisive role in...
Nasdaq GlobeNewswire
16/10/2024
New data on aprocitentan to be presented at the ASN Kidney Week 2024
Allschwil, Switzerland – October 16, 2024Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan, Idorsia's endothelin receptor antagonist, will be presented at the American Society of Nephrology (ASN) Kidney Week 2024, taking place in San Diego, CA, October 23–27, 2024.The following oral and poster presentations will be held, highlighting the promising results of using aprocitentan for patients with hypertension not adequately controlled with other medications, with...
Nasdaq GlobeNewswire
16/10/2024
Metastatic Castration-Sensitive Prostate Cancer Clinical Trial Pipeline Insights…
Key Takeaways from the Metastatic Castration-Sensitive Prostate Cancer Pipeline Report Key Takeaways from the Metastatic Castration-Sensitive Prostate Cancer Pipeline Report Request a sample and discover the recent advances in mCSPC treatment drugs @ Metastatic Castration-Sensitive Prostate Cancer Pipeline Report The mCSPC pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage mCSPC drugs, inactive and dormant assets,...
PR Newswire
15/10/2024
AtomVie Global Radiopharma and Radiopharm Theranostics Partner to Develop and…
This collaboration brings together RAD's world-class platform of radiotherapeutic products and AtomVie's leading in manufacturing and distributing radiopharmaceuticals globally. 177Lu-BetaBart is part of a broader pipeline of distinct, highly differentiated technologies developed by RAD and RV. These span peptides, small molecules, and monoclonal antibodies for use in cancer, sourced from top-tier universities and institutes globally. The pipeline is designed with the strong potential to be…
PR Newswire
15/10/2024
Global Contract Pharmaceutical Manufacturing, Research, and Packaging Markets…
The global pharmaceutical contract manufacturing, research, and packaging market is a dynamic landscape poised for substantial growth from 2024 to 2029. BCC Research provides a comprehensive analysis, offering insights into market size starting from 2023 and projections through the next five years. The contract manufacturing segment is meticulously examined across various dimensions including product type, dosage form, drug molecule type, and delivery technologies across different regions…
PR Newswire
15/10/2024
Publication relating to transparency notifications
REGULATED INFORMATIONPublication relating to transparency notificationsMont-Saint-Guibert(Belgium), October 15, 2024 , 10:30 pm CET / 4:30 pm ET –In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received three transparency notifications as detailed below.Jürgen HambrechtOn October 15, 2024, Nyxoah received a transparency notification from...
Nasdaq GlobeNewswire
15/10/2024
Sanofi: Information concerning the total number of voting rights and shares -…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,537,214,304 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris...
Nasdaq GlobeNewswire
15/10/2024
Endo to Host Investor Call on Third-Quarter 2024 Financial Results
A replay of the webcast will be available within 24 hours at investor.endo.com. A replay of the webcast will be available within 24 hours atinvestor.endo.com. About EndoEndo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more atwww.endo.comor...
PR Newswire
15/10/2024
MDisrupt Secures American Heart Association Ventures Investment, Enters…
In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the health technology, health services, medical device and life sciences sectors. This collaboration will enable members to advance the Association's mission of spreading evidence-based, high-quality scientific expertise across the healthcare ecosystem. In addition, MDisrupt will add new...
PR Newswire
15/10/2024
InSphero and FDA's NCTR Publish the Largest Benchmarking Study Demonstrating…
"Our work with the FDA's NCTR is a breakthrough in liver toxicology research and sets a new industry standard," said Dr. Jan Lichtenberg, CEO and Co-founder of InSphero. "The 152 FDA-approved compounds used for this study had all undergone classical preclinical and clinical safety testing, including studies in animals. Despite this, some compounds were later withdrawn due to liver safety concerns. We were able to correctly flag 80% of these withdrawn compounds using a…
PR Newswire
15/10/2024
Dreame enters UK market with the launch of flagship products
Founded in 2017, Dreame has quickly become a global leader in home cleaning technology, pioneering industry firsts. The company was the first to launch a robotic vacuum with a Robotic Flex Arm, designed to tackle hard-to-reach areas with ease. Dreame's innovation also extends to engineering the world's fastest digital motor at 200,000 RPM, delivering exceptional suction power for deeper, more efficient cleaning. Until this year, Dreame has made significant strides in the robotic vacuum market…
PR Newswire
15/10/2024
Spineway : Continued organic growth - Nine-month 2024 revenue of €9.1 million…
Press release Ecully, October 15, 2024 – 6 p.m. SPINEWAYContinued organic growth Nine-month 2024 revenue of €9.1 million (+21%)In thousands of euros 20242023Change %Q1 revenue3,0702,39828%Q2 revenue3,4653,03314%Q3 revenue2,5752,07724% 9M revenue9,1107,51021%Unaudited consolidated data The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, recorded an...
Nasdaq GlobeNewswire
15/10/2024
Casino Group: Appointment within Casino Group's central purchasing unit
Appointment within Casino Group's central purchasing unit Paris, 15 October 2024 Béatrice AVRIL has been appointed Head of Food and Non-Food Purchasing for the Group at Achats Marchandises Casino (AMC). Béatrice AVRIL, formerly Director of Private Label Food Purchasing, has been appointed Head of Food and Non-Food Purchasing for Casino Group at Achats Marchandises Casino (AMC). She will report to Hervé DAUDIN, Chairman of AMC and a member of Casino Group Executive Committee. This...
Nasdaq GlobeNewswire
15/10/2024
EUROAPI closes the financing of its FOCUS-27 plan
Press Release Paris - 15 October 2024 -EUROAPI today announces the closing of the refinanced Credit Revolving Facility (RCF) and the Perpetual Deeply Subordinated Hybrid Bond subscribed by Sanofi, thus completing the financing of its FOCUS-27 strategic plan. About EUROAPIEUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers' and patients' needs around the world. We are a leading player in active pharmaceutical ingredients with...
Nasdaq GlobeNewswire
15/10/2024
Healthcare EDI Market to Hit USD 7.11 Billion by 2029 with 9.7% CAGR |…
Browse in-depth TOC on "Healthcare EDI Market" Browse in-depth TOC on "Healthcare EDI Market" 200 - Tables 50 - Figures 250 - Pages The rising shift towards the use of automated data validation with artificial intelligence (AI), cloud-based EDI solutions, the expansion of API-based plug-ins, and the increased adoption of blockchain technology to enhance security are expected to bolster the growth of the healthcare EDI market. Moreover, to promote health data...
PR Newswire
15/10/2024
PharmaMar Announces Positive and Statistically Significant Overall Survival and…
"The results of the Phase 3 IMforte trial are highly encouraging and showed a statistically significant benefit for the lurbinectedin and atezolizumab combination for extensive-stage small cell lung cancer patients receiving this treatment in the first-line maintenance setting. These results demonstrate the potential of this regimen to delay disease progression and extend survival for patients with this aggressive disease," said Rob Iannone, M.D., M.S.C.E., executive vice president…
PR Newswire
15/10/2024
Cell Based Assay Market Poised for Significant Growth, projected to Reach USD…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=201801 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=201801 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Cell Based Assay Market Overview Market Definition and Scope The Cell Based Assay Market refers to the segment of the pharmaceutical and biotechnology industries focused on testing cellular responses to various compounds,...
PR Newswire
15/10/2024
Cellular Health Screening & Health Testing Market Poised for Remarkable Growth…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1014477 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1014477 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Cellular Health Screening & Health Testing Market Overview Market Growth and Projections The Cellular Health Screening & Health Testing Market is experiencing rapid growth, driven by increasing consumer awareness...
PR Newswire
15/10/2024
Neurogenomics Market to Reach $4.68 Billion by 2031--Exclusive Report by…
Download FREE PDF Brochure Of Neurogenomics Market - Download FREE PDF Brochure Of Neurogenomics Market - https://www.meticulousresearch.com/download-sample-report/cp_id=6019 Neurogenomics is a multidisciplinary field that integrates genome sciences and neurobiology. It examines the genome's impact on the structure, evolution, development, and functionality of the nervous system. This research encompasses genetic analyses, including the assessment of genome sequencing outputs like...
PR Newswire
15/10/2024
Body Contouring Devices Market to Hit USD 3.00 Billion by 2029 with 11.4% CAGR |…
Browse in-depth TOC on "Body Contouring Devices Market" Browse in-depth TOC on "Body Contouring Devices Market" 349 - Tables 44 - Figures 309 - Pages By product, the body contouring devices market is segmented into non-invasive and invasive devices. In 2023, the non-invasive devices segment held the majority share in the body contouring devices market. The largest portion of non-invasive segment is driven by added benefits offered by the non-invasive device, predominantly...
PR Newswire
15/10/2024
Monument Therapeutics Secures £1M Investment to Fund Its Schizophrenia Programme…
Dr Randeep Grewal, who has served as a board observer at Monument representing angel investors since 2022, has been appointed as board Chair. Randeep brings extensive experience from his other roles as Chair of Bellevue Healthcare Trust and non-executive director of organisations including Hox Therapeutics, the Global Smaller Companies Trust and the Monks Investment Trust. Furthermore, his previous background as a fund manager and a vascular surgeon provides a unique blend of financial and…
PR Newswire
15/10/2024
Altri Comunicati